Maxlotec rises 5.1% amid COVID-19 (Remdesivir) theme uptrend

On the 4th, the COVID-19 (Remdesivir) theme rose by 3.06% compared to the previous day, showing strength, while Maxrotech, a related stock attracting attention, surged by 5.1% compared to the previous day. Maxrotech is known as a manufacturer of wired and wireless gantry robots and engine cylinder blocks for automobiles.

[Graph] Major stock price changes in the COVID-19 (Remdesivir) theme

According to preliminary data compiled at 10:19, foreigners are net selling 5,000 shares (-0.50 ten thousand shares) of Maxrotech.

[Table] Net trading volume of foreigners and institutions (unit: ten thousand shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Maxrotech's quant financial score is 1.07 points, which is lower in stability, profitability, and growth compared to the average of other stocks related to COVID-19 (Remdesivir). This can be interpreted as Maxrotech having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, BC World Pharm ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the robo algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.